Showing results (1151-1160 of 7,010) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|March 30, 2010
A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancerJoseph Treat, Martin J Edelman, Chandra P Belani, et al.
Lung Cancer (Amsterdam, Netherlands)|April 20, 2010
The function of IGF-IR in NNK-mediated lung tumorigenesisMegan D Siwicky, James J Petrik, Roger A Moorehead
Lung Cancer (Amsterdam, Netherlands)|April 20, 2010
Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study)Jean-François Morère, Jeanne-Marie Bréchot, Virginie Westeel, et al.
Lung Cancer (Amsterdam, Netherlands)|April 16, 2010
Automated assessment of malignant degree of small peripheral adenocarcinomas using volumetric CT data: correlation with pathologic prognostic factorsMasahiro Yanagawa, Yuko Tanaka, Masahiko Kusumoto, et al.
Lung Cancer (Amsterdam, Netherlands)|February 3, 2009
Oxygen uptake kinetics during cardiopulmonary exercise testing and postoperative complications in patients with lung cancerErdem Kasikcioglu, Alper Toker, Serhan Tanju, et al.
Lung Cancer (Amsterdam, Netherlands)|February 6, 2009
Spontaneous remission of a non-small cell lung cancer possibly caused by anti-NY-ESO-1 immunityYoichi Nakamura, Yuji Noguchi, Eiichi Satoh, et al.
Lung Cancer (Amsterdam, Netherlands)|March 31, 2009
Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II studyV Surmont, J G Aerts, E Pouw, et al.
Lung Cancer (Amsterdam, Netherlands)|March 31, 2009
Targeted reduction of KLF6-SV1 restores chemotherapy sensitivity in resistant lung adenocarcinomaJaya Sangodkar, Analisa DiFeo, Lauren Feld, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2010
Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancerWen-Pin Su, Yen-Ting Chen, Wu-Wei Lai, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2010
Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapyYohei Imamura, Koichi Azuma, Seiji Kurata, et al.
Pageof 701